Screener
Biohaven BHVN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 12) | ||
| Shareholders' (Deficit) Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 150,506,490 and 132,775,113 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2,132,908 | 1,934,276 |
| Additional paid-in capital | 203,358 | 193,984 |
| Accumulated deficit | (2,215,068) | (2,084,536) |
| Accumulated other comprehensive income | 8,302 | 8,348 |
| Total shareholders' (deficit) equity | 129,500 | 52,072 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's common stock?
- Biohaven (BHVN) reported common stock of 200M in Q1 2026.
- How has Biohaven's common stock changed year-over-year?
- Biohaven's common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Biohaven's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude